As of 2024-12-14, the Intrinsic Value of Inozyme Pharma Inc (INZY) is
-7.51 USD. This INZY valuation is based on the model Peter Lynch Fair Value.
With the current market price of 3.03 USD, the upside of Inozyme Pharma Inc is
-347.87%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-7.51 USD
Intrinsic Value
INZY Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-7.51 - -7.51 |
-7.51 |
-347.87% |
| P/E |
(24.93) - (25.99) |
(21.59) |
-812.6% |
| DDM - Stable |
(10.75) - (28.09) |
(19.42) |
-741.0% |
| DDM - Multi |
(7.26) - (14.86) |
(9.77) |
-422.4% |
INZY Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
194.65 |
| Beta |
2.49 |
| Outstanding shares (mil) |
64.24 |
| Enterprise Value (mil) |
215.72 |
| Market risk premium |
4.60% |
| Cost of Equity |
11.29% |
| Cost of Debt |
5.00% |
| WACC |
9.67% |